Maternal vitamin D status and the risk of mild and severe preeclampsia

Epidemiology

Volumn 25, Issue 2, 2014, Pages 207-214

  Bodnar, Lisa M ^a,b,c   Simhan, Hyagriv N ^b,c   Catov, Janet M ^a,b,c   Roberts, James M ^a,b,c   Platt, Robert W ^d   Diesel, Jill C ^a   Klebanoff, Mark A ^e,f  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^f THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; LOGISTIC MODELS; MARKOV CHAINS; MONTE CARLO METHOD; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TANDEM MASS SPECTROMETRY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84894087352     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000039     Document Type: Article

References (51)

1. R oberts JM. Pregnancy related hypertension. In: Creasy RK, Resnik R, eds. Maternal Fetal Medicine. Philadelphia, Pa: W.B. Saunders; 1998:883-872
2. G oldenberg RL, Rouse DJ. Prevention of premature birth. N Engl J Med. 1998;339:313-320
3. AC OG Practice Bulletin No. 33. Diagnosis and management of preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2002;99:159-167
4. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266-281
5. L ooker AC , Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr. 2008;88:1519-1527
6. Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr. 2007;137:447-452
7. Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J Nutr. 2009;139:1157-1161
8. Johnson DD, Wagner CL, Hulsey TC, McNeil RB, Ebeling M, Hollis BW. Vitamin D deficiency and insufficiency is common during pregnancy. Am J Perinatol. 2011;28:7-12
9. A dams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab. 2010;95:471-478
10. L apillonne A. Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes. Med Hypotheses. 2010;74:71-75
11. E vans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placentaldecidual function. J Soc Gynecol Investig. 2004;11:263-271
12. L iu NQ, Ouyang Y, Bulut Y, et al. Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. Endocrinology. 2013;154:2270-2280
13. Powe CE, Seely EW, Rana S, et al. First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension. 2010;56:758-763
14. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92:3517-3522
15. Baker AM, Haeri S, Camargo CA Jr, Espinola JA, Stuebe AM. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. J Clin Endocrinol Metab. 2010;95:5105-5109
16. Shand AW, Nassar N, Von Dadelszen P, Innis SM, Green TJ. Maternal vitamin D status in pregnancy and adverse pregnancy outcomes in a group at high risk for pre-eclampsia. BJOG. 2010;117:1593-1598
17. Yu CK, Ertl R, Skyfta E, Akolekar R, Nicolaides KH. Maternal serum vitamin D levels at 11-13 weeks of gestation in preeclampsia. J Hum Hypertens. 2013;27:115-118
18. Wei SQ, Audibert F, Hidiroglou N, et al. Longitudinal vitamin D status in pregnancy and the risk of pre-eclampsia. BJOG. 2012;119:832-839
19. HyppÖnen E, Hartikainen AL, Sovio U, Järvelin MR, Pouta A. Does vitamin D supplementation in infancy reduce the risk of pre-eclampsiä Eur J Clin Nutr. 2007;61:1136-1139
20. Haugen M, Brantsaeter AL, Trogstad L, et al. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology. 2009;20:720-726
21. A ghajafari F, Nagulesapillai T, Ronksley PE, Tough SC, OaBeirne M, Rabi DM. Association between maternal serum 25-hydroxyvitamin D level and pregnancy and neonatal outcomes: Systematic review and metaanalysis of observational studies. BMJ. 2013;346:f1169
22. C ologne J, Preston DL, Imai K, et al. Conventional case-cohort design and analysis for studies of interaction. Int J Epidemiol. 2012;41:1174-1186
23. N iswander K. The Collaborative Perinatal Study of the National Institute of Neurological Diseases and Stroke: The Women and Their Pregnancies. Philadelphia, Pa: WB Saunders; 1972
24. Friedman EA, Neff RK. Pregnancy Hypertension: A Systematic Evaluation of Clinical Diagnostic Criteria. Littleton, Mass: PSG Publishing Co.; 1977
25. N ational High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22
26. Holick MF, Siris ES, Binkley N, et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab. 2005;90:3215-3224
27. Zerwekh JE. The measurement of vitamin D: Analytical aspects. Ann Clin Biochem. 2004;41(pt 4):272-281
28. Bodnar LM, Catov JM, Wisner KL, Klebanoff MA. Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years. Br J Nutr. 2009;101:278-284
29. I OM. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academy Press; 2010
30. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911-1930
31. R oyston P. Multiple imputation of missing values: Further update of ice, with an emphasis on categorical variables. Stata Journal 2009;9:466-477
32. Sterne JA, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: Potential and pitfalls. BMJ. 2009;338:b2393
33. R othman KJ. Synergy and antagonism in cause-effect relationships. Am J Epidemiol. 1974;99:385-388
34. Vander Weele TJ. On the distinction between interaction and effect modification. Epidemiology. 2009;20:863-871
35. R othman KJ, Greenland S, Walker AM. Concepts of interaction. Am J Epidemiol. 1980;112:467-470
36. Pearl J. Causal diagrams for empirical research. Biometrika. 1995;82: 669-688
37. Weng HY, Hsueh YH, Messam LL, Hertz-Picciotto I. Methods of covariate selection: Directed acyclic graphs and the change-in-estimate procedure. Am J Epidemiol. 2009;169:1182-1190
38. L ash TL, Fink AK. Semi-Automated sensitivity analysis to assess systematic errors in observational data. Epidemiology. 2003;14:451-458
39. Freedman DM, Cahoon EK, Rajaraman P, et al. Sunlight and other determinants of circulating 25-hydroxyvitamin D levels in black and white participants in a nationwide U.S. study. Am J Epidemiol. 2013;177:180-192
40. Van Dam RM, Snijder MB, Dekker JM, et al. Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: The Hoorn Study. Am J Clin Nutr. 2007;85:755-761
41. HyppÖnen E, Power C. Hypovitaminosis D in British adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr. 2007;85:860-868
42. Kasawara KT, do Nascimento SL, Costa ML, Surita FG, esilva JL. Exercise and physical activity in the prevention of pre-eclampsia: Systematic review. Acta Obstet Gynecol Scand. 2012;91:1147-1157
43. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-ec lampsia or intrauterine growth restriction. Cochrane Database Syst Rev. 2006:CD003402
44. Buchbinder A, Sibai BM, Caritis S, et al; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002;186:66-71
45. Zhang J, Klebanoff MA, Roberts JM. Prediction of adverse outcomes by common definitions of hypertension in pregnancy. Obstet Gynecol. 2001;97:261-267
46. Haugen G, Helland I. Influence of preeclampsia or maternal intake of omega-3 fatty acids on the vasoactive effect of prostaglandin F-Two-Alpha in human umbilical arteries. Gynecol Obstet Invest. 2001;52:75-81
47. Wei SQ, Audibert F, Luo ZC, et al; MIROS Study Group. Maternal plasma 25-hydroxyvitamin D levels, angiogenic factors, and preeclampsia. Am J Obstet Gynecol. 2013;208:390.e1-390.e6
48. T abesh M, Salehi-Abargouei A, Tabesh M, Esmaillzadeh A. Maternal vitamin D status and risk of pre-eclampsia: A systematic review and metaanalysis. J Clin Endocrinol Metab. 2013;98:3165-3173
49. von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy. 2003;22:143-148
50. R obinson CJ, Alanis MC, Wagner CL, Hollis BW, Johnson DD. Plasma 25-hydroxyvitamin D levels in early-onset severe preeclampsia. Am J Obstet Gynecol. 2010;203:366.e1-366.e6
51. R edman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-1594